Ładuje się......
MET targeted therapy for lung cancer: clinical development and future directions
MET, the receptor for hepatocyte growth factor, has been identified as a novel promising target in various human malignancies, including lung cancer. Research studies have demonstrated that MET signaling plays important physiologic roles in embryogenesis and early development, whereas its deregulati...
Zapisane w:
| Wydane w: | Lung Cancer (Auckl) |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Dove Medical Press
2012
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5312490/ https://ncbi.nlm.nih.gov/pubmed/28210125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S23423 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|